{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:47Z","timestamp":1791221867608,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.10.048","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:23:15Z","timestamp":1540347795000},"page":"250-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies"],"prefix":"10.1016","volume":"83","author":[{"given":"Mohamed M.","family":"El-Kerdawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam A.","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad R.","family":"Elsheakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab S.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.10.048_b0005","series-title":"Principles of Medicinal Chemistry","first-page":"988","author":"Foye","year":"2013"},{"key":"10.1016\/j.bioorg.2018.10.048_b0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/op960009e","article-title":"Large-scale synthetic process for (S)-naproxen by Syntex","volume":"1","author":"Harrington","year":"1997","journal-title":"Org. Process Res. Dev"},{"key":"10.1016\/j.bioorg.2018.10.048_b0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.107.122283","article-title":"Human Pharmacology of naproxen sodium","volume":"322","author":"Capone","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2018.10.048_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1211\/002235703765344577","article-title":"Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease","volume":"55","author":"Rainsford","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2018.10.048_b0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs","volume":"38","author":"Grosser","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2018.10.048_b0030","first-page":"30717","article-title":"The risk of major NSAID toxicity with celecoxib, ibuprofen, or naproxen: A secondary analysis of the PRECISION trial","volume":"S0002\u20139343","author":"Solomon","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2018.10.048_b0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40265-015-0521-8","article-title":"Sumatriptan\/naproxen sodium: A review in migraine","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2018.10.048_b0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bioorg.2017.11.002","article-title":"Design, synthesis, anti-inflammatory antitumor activities, molecular modeling and molecular dynamics simulations of potential Naprosyn\u00ae analogs as COX-1 and\/or COX-2 inhibitors","volume":"76","author":"El Sayed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2018.10.048_b0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/08923978009026408","article-title":"Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633)","volume":"2","author":"Fenichel","year":"1980","journal-title":"J. Immunopharm."},{"key":"10.1016\/j.bioorg.2018.10.048_b0050","first-page":"10","article-title":"WY 18,251 (Tilomisole), an analog of levamisole: tolerability, and immune modulating effects in cancer patients","volume":"4","author":"Dillman","year":"1992","journal-title":"Mol. Biotherap."},{"key":"10.1016\/j.bioorg.2018.10.048_b0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Review: Nonsteroidal anti-inflammatory drugs as anticancer: Mechanistic, Pharmacologic, and clinical Issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.bioorg.2018.10.048_b0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bioorg.2018.10.048_b0065","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1248\/bpb.27.786","article-title":"Dual inhibition of cyclooxygenases-2 and 5-libooxgynase by deoxypodophyllotoxin (anthricin) in mouse bone marrow-derived mast cells","volume":"27","author":"Lee","year":"2004","journal-title":"Biol. Pharma. Bulletin"},{"key":"10.1016\/j.bioorg.2018.10.048_b0070","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.bmc.2011.06.019","article-title":"Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents","volume":"19","author":"Manivannan","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.048_b0075","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/jm0002634","article-title":"Flexible alignment of small molecules","volume":"44","author":"Labute","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.10.048_b0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0898-5529(90)90162-2","article-title":"An alternative method for the alignment of molecular structures: maximizing electrostatic and steric overlap","volume":"3","author":"Kearsley","year":"1990","journal-title":"Tetrahedron Comput. Methodol."},{"key":"10.1016\/j.bioorg.2018.10.048_b0085","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon forcefield utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.10.048_b0090","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1021\/ja00293a019","article-title":"Molecular mechanics calculations on aliphatic amines","volume":"107","author":"Profeta","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.10.048_b0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Auto Dock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2018.10.048_b0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2018.10.048_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and rekiability","volume":"22","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2018.10.048_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jhet.5570450413","article-title":"Syntheis of some novel pyrazolo [1,5-a]pyrimidine, 1,2,4-triazolo[1,5-a]pyrimidine, pyrido[2,3-d]pyrimidine, pyrazolo[5,1-c] -1,2,4-triazine and 1,2,4-triazolo[5,1-c]-1,2,4-triazine derivatives incorporating a thiazolo [3,2-a]benzimidazole moiety","volume":"45","author":"Abdel-Aziz","year":"2008","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2018.10.048_b0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jhet.584","article-title":"Synthesis of some new azole, pyrimidine, pyran, and benzo\/naphtha[b]furan derivatives incorporating thiazolo [3,2-a]benzimidazole moiety","volume":"48","author":"Farag","year":"2011","journal-title":"J. Heterocycl. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:14:59Z","timestamp":1720707299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818306746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":23,"alternative-id":["S0045206818306746"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.048","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}